EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer

NCT07698613 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection
Pancreatic Cancer Borderline
Pancreatic Cancer Resectable

Interventions

COMBINATION_PRODUCT: ASP-1929 photoimmunotherapy

Sponsor

Brown University

Collaborators

[object Object]
[object Object]
[object Object]